Clinical Characteristics of Inflammatory Bowel Disease Patients Requiring Long-Term Parenteral Support in the Present Era of Highly Effective Biologic Therapy.
Michael KurinAlyce AndersonClaudia Ramos RiversFilippos KoutroumpakisPatricia CentaJuliette Bender-HeineGina KozakElisabeth KramerStephen J O'KeefeDavid C WhitcombLevinthal DjIoannis E KoutroubakisMichael A DunnJana G HashashDavid G BinionPublished in: JPEN. Journal of parenteral and enteral nutrition (2020)
IBD patients requiring long-term home PN/IVF support are a small minority in the present era of immunomodulator/biologic therapy. These refractory patients have a 15-fold increase in annual median healthcare charges compared with control IBD patients.